APADAZ FDA approval date

The FDA approved APADAZ on 23 Feb 2018.

FDA approval date
23 Feb 2018

Drug identity has not yet been verified against registry records

Also recorded as ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-02-23DayAPADAZFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208653", "applicant_as_listed_by_fda": "ZEVRA THERAP", "brand_names": ["APADAZ"], "active_ingredients": ["ACETAMINOPHEN", "BENZHYDROCODONE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180223", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026